These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 1846948)

  • 1. Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice.
    Frankel WN; Rudy C; Coffin JM; Huber BT
    Nature; 1991 Feb; 349(6309):526-8. PubMed ID: 1846948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genes encoding ligands for deletion of V beta 11 T cells cosegregate with mammary tumour virus genomes.
    Dyson PJ; Knight AM; Fairchild S; Simpson E; Tomonari K
    Nature; 1991 Feb; 349(6309):531-2. PubMed ID: 1846950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
    Simpson E; Takacs K; Altmann DM
    Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells.
    Foo-Phillips M; Kozak CA; Principato MA; Abe R
    J Immunol; 1992 Dec; 149(11):3440-7. PubMed ID: 1331236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An endogenous retrovirus mediating deletion of alpha beta T cells?
    Woodland DL; Happ MP; Gollob KJ; Palmer E
    Nature; 1991 Feb; 349(6309):529-30. PubMed ID: 1846949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A maternally inherited superantigen encoded by a mammary tumour virus.
    Marrack P; Kushnir E; Kappler J
    Nature; 1991 Feb; 349(6309):524-6. PubMed ID: 1846947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologic expression of two superantigens in the BDF1 mouse.
    Gollob KJ; Palmer E
    J Immunol; 1991 Oct; 147(8):2447-54. PubMed ID: 1655891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Mls-1 locus and clonal deletion of T cells in susceptibility to collagen-induced arthritis in mice.
    Anderson GD; Banerjee S; Luthra HS; David CS
    J Immunol; 1991 Aug; 147(4):1189-93. PubMed ID: 1907992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that Mls-2 antigens which delete V beta 3+ T cells are controlled by multiple genes.
    Pullen AM; Marrack P; Kappler JW
    J Immunol; 1989 May; 142(9):3033-7. PubMed ID: 2496158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
    Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
    J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mls-1 and Mls-2 superantigens do not control susceptibility to collagen-induced arthritis in HI and HII mice.
    Roger T; Boudaly S; Couderc J; Seman M
    Immunology; 1993 Dec; 80(4):661-3. PubMed ID: 8307618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell recognition of Mls-like superantigens: analysis of TCR requirements, superantigenic ligands, and signal transduction.
    Hodes RJ; Abe R
    Semin Immunol; 1992 Oct; 4(5):319-27. PubMed ID: 1336682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of T cell function by Mtv-7 gene products.
    Hoffmann MK; Dannecker G; Mecheri S
    Semin Immunol; 1992 Oct; 4(5):337-51. PubMed ID: 1336683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A kinetic study on the deletion of thymic, peripheral, and gut-associated V beta 6+ T cells in an Mls-1b BALB/c colony infected with an exogenous mouse mammary tumor virus.
    Tucek CL; Desaymard C; Papiernik M
    J Immunol; 1993 Jul; 151(2):759-66. PubMed ID: 8101538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of T cell receptor V beta gene usage in primary mixed lymphocyte reactions: evidence for directive usage by different antigen-presenting cells and Mls-like determinants on T cell blasts.
    Larsson-Sciard EL; Spetz-Hagberg AL; Casrouge A; Kourilsky P
    Eur J Immunol; 1990 Jun; 20(6):1223-9. PubMed ID: 2142455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mls superantigens: how retroviruses influence the expressed T cell receptor repertoire.
    Huber BT
    Semin Immunol; 1992 Oct; 4(5):313-8. PubMed ID: 1336681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a new minor lymphocyte stimulatory system. I. Cluster of self antigens recognized by "I-E-reactive" V beta s, V beta 5, V beta 11, and V beta 12 T cell receptors for antigen.
    Abe R; Kanagawa O; Sheard MA; Malissen B; Foo-Phillips M
    J Immunol; 1991 Aug; 147(3):739-49. PubMed ID: 1713604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex.
    Kappler JW; Staerz U; White J; Marrack PC
    Nature; 1988 Mar; 332(6159):35-40. PubMed ID: 3126396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens.
    MacDonald HR; Schneider R; Lees RK; Howe RC; Acha-Orbea H; Festenstein H; Zinkernagel RM; Hengartner H
    Nature; 1988 Mar; 332(6159):40-5. PubMed ID: 3126397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal deletion of V beta 14-bearing T cells in mice transgenic for mammary tumour virus.
    Acha-Orbea H; Shakhov AN; Scarpellino L; Kolb E; Müller V; Vessaz-Shaw A; Fuchs R; Blöchlinger K; Rollini P; Billotte J
    Nature; 1991 Mar; 350(6315):207-11. PubMed ID: 1848685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.